发明公开
EP2086540A1 TRIAZOLOPYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES
有权
TRIAZOLOPYRIDINVERBINDUNGEN用于治疗退化性疾病和炎性疾病
- 专利标题： TRIAZOLOPYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES
- 专利标题（中）： TRIAZOLOPYRIDINVERBINDUNGEN用于治疗退化性疾病和炎性疾病
-
申请号： EP07857236.9申请日： 2007-11-30
-
公开(公告)号： EP2086540A1公开(公告)日： 2009-08-12
- 发明人: BURRITT, Andrew , EDWARDS, Paul John , SCHMIDT, Wolfgang , BIRAULT, Veronique , KROLL, Friedrich Erich Karl , TAO, Xueliang , ANDREWS, Martin James Inglis , MARTINA, Sébastien Laurent Xavier
- 申请人： Galapagos N.V. , BURRITT, Andrew
- 申请人地址： Generaal de Wittelaan L11 A3 2800 Mechelen BE
- 专利权人： Galapagos N.V.,BURRITT, Andrew
- 当前专利权人： Galapagos N.V.,BURRITT, Andrew
- 当前专利权人地址： Generaal de Wittelaan L11 A3 2800 Mechelen BE
- 代理机构： Nichol, Maria Zenarosa
- 优先权： US868144P 20061201
- 国际公布： WO2008065198 20080605
- 主分类号： A61K31/437
- IPC分类号： A61K31/437 ; C07D471/04 ; A61P29/00
摘要：
Novel triazolopyridine compounds are disclosed that have a formula represented by Formula (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non- limiting example, ECM degradation, joint degradation and/or inflammation, and others.
公开/授权文献
信息查询
IPC分类:
